New Stent-Graft device under scrutiny for treating dangerous aortic aneurysms
NCT ID NCT07147569
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 100 people with thoracoabdominal or pararenal aortic aneurysms who receive the GORE EXCLUDER TAMBE device, a stent-graft system placed through blood vessels. Researchers will track how often the device is successfully implanted and works without leaks or serious complications over 12 months. The goal is to confirm the device's safety and effectiveness in real-world use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (a stent-graft device)
What this could lead to
If successful, this could confirm that the device is a safe, effective option for treating complex aortic aneurysms without open surgery.
What could go wrong
This is an observational post-market study, not a randomized trial. Results may not apply to all patients, and risks include serious complications like stroke, paralysis, or kidney failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THORACOABDOMINAL AORTIC ANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Morinomiya Hospital
RECRUITINGOsaka, Japan
-
Nagoya University Hospital
RECRUITINGNagoya, Japan
-
Osaka International Medical & Science Center Osaka Police Hospital
RECRUITINGOsaka, Japan
-
The Jikei University Hospital
RECRUITINGMinatoku, Japan
-
The University of Osaka Hospital
RECRUITINGSuita, Japan